ImmunityBio Inc. Common Stock vs Mizuho Financial Group Inc. Sponosred ADR (Japan) — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B), while Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.58 (market cap $132.18B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 12.8× ImmunityBio Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.7% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days on average.
| IBRX | MFG | |
|---|---|---|
Market Cap | $10.33B | $132.18B |
Volume | 11,745,198 | 3,264,662 |
Sector | Health | Financials |
52-Week High | $11.55 | $11.45 |
52-Week Low | $1.98 | $6.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $35.48T |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →